Drug Approval | February 21, 2025
PAT after MI is Rs. 41 crore which is 162% increase
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
The product will be marketed by Dr. Reddy's
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA
The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
Global specialty pipeline accelerates growth
Company leadership is framing the move as transformational.
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
